Human Monoclonal Antibodies against Anthrax Lethal Factor and Protective Antigen Act Independently To Protect against Bacillus anthracis Infection and Enhance Endogenous Immunity to Anthrax

The unpredictable nature of bioterrorism and the absence of real-time detection systems have highlighted the need for an efficient postexposure therapy for Bacillus anthracis infection. One approach is passive immunization through the administration of antibodies that mitigate the biological action...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Albrecht, Mark T., Li, Han, Williamson, E. Diane, LeButt, Chris S., Flick-Smith, Helen C., Quinn, Conrad P., Westra, Hans, Galloway, Darrell, Mateczun, Alfred, Goldman, Stanley, Groen, Herman, Baillie, Les W. J.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 2007
Matèries:
Microbial Immunity and Vaccines
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2168292/
https://ncbi.nlm.nih.gov/pubmed/17646360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.00261-07
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars